CS/ODex/β-GP Injectable Hydrogel
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Injectable
-
Intended Duration:
- Not Yet Determined
- Development Stage: Discovery & Early Development
- Developer(s)/researcher(s): Northeast Forestry University, National Research Institute for Family Planning
Details
- API: Ethinylestradiol
- Target: Estrogen Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Inactive Materials: CS/ODex/β-GP Hydrogel
- Regimen: Not Yet Determined
- MPT: Not Potential MPT
- Promising Attributes: Not Yet Established - Concept is in Early Development
Product Status
Active/Recent Early Development
History
2025: Researchers publish results of a 240hr drug release study that demonstrated sustained EE release from a hydrogel-based injectable.